Public outcry has erupted in India as people demand a full investigation into the deaths of 14 children linked to the cough syrup brand Coldrif. The country also faces scrutiny after its syrups were linked to child deaths in Gambia, Cameroon, and Uzbekistan. (Graphic content)
Breakdown
- Fourteen children died of kidney failure after taking the cough syrup Coldrif.
- Lab tests found the syrup contained 48 times the permissible limit of diethylene glycol. 9s
- A paediatrician was arrested for prescribing the syrup after reports of adverse effects. 44s
- Authorities banned the syrup, but protests demand further accountability from officials. 57s
- The case has drawn attention to previous international incidents involving Indian cough syrups. 1m 33s